|
1
|
Reik W: Evolution and functions of long
noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wahlestedt C: Targeting long non-coding
RNA to therapeutically upregulate gene expression. Nat Rev Drug
Discov. 12:433–446. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW and Liu XS:
Integrative analyses reveal a long noncoding RNA-mediated sponge
regulatory network in prostate cancer. Nat Commun. 7:109822016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhan A and Mandal SS: LongNoncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2015. View Article : Google Scholar
|
|
7
|
Heo JB, Lee YS and Sung S: Epigenetic
regulation by long noncoding RNAs in plants. Chromosome Res.
21:685–693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schonrock N, Harvey RP and Mattick JS:
Long noncoding RNAs in cardiac development and pathophysiology.
Circ Res. 111:1349–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carrieri C, Forrest A, Santoro C,
Persichetti F, Carninci P, Zucchelli S and Gustincich S: Expression
analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1)
during dopaminergic cells' differentiation in vitro and in
neurochemical models of Parkinson's disease. Front Cell Neurosci.
9:1142015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rinn JL: lncRNAs: Linking RNA to
chromatin. Cold Spring Harb Perspect Biol. 6(pii): a0186142014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kunej T, Obsteter J, Pogacar Z, Horvat S
and Calin GA: The decalog of long non-coding RNA involvement in
cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 51:344–357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA Taurine Upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Lu Y, Li R, Yan N, Li X and Dai T:
Prognostic role of long non-coding RNA TUG1 expression in various
cancers: A meta-analysis. Oncotarget. 8:100499–100507.
2017.PubMed/NCBI
|
|
20
|
Li N, Shi K, Kang X and Li W: Prognostic
value of long non-coding RNA TUG1 in various tumors. Oncotarget.
8:65659–65667. 2017.PubMed/NCBI
|
|
21
|
Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang
X, Jiang R, Cai Z and Wu S: Downregulation of the long noncoding
RNA TUG1 inhibits the proliferation, migration, invasion and
promotes apoptosis of renal cell carcinoma. J Mol Histol.
47:421–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuang D, Zhang X, Hua S, Dong W and Li Z:
Long non-coding RNA TUG1 regulates ovarian cancer proliferation and
metastasis via affecting epithelial-mesenchymal transition. Exp Mol
Pathol. 101:267–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han Y, Liu Y, Gui Y, Gui Y and Cai Z: Long
intergenic non-coding RNA TUG1 is overexpressed in urothelial
carcinoma of the bladder. J Surg Oncol. 107:555–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long
C, Pei Z and Fa-Ming T: LncRNA TUG1 is upregulated and promotes
cell proliferation in osteosarcoma. Open Med (Wars). 11:163–167.
2016.PubMed/NCBI
|
|
25
|
Liang S, Zhang S, Wang P, Yang C, Shang C,
Yang J and Wang J: LncRNA, TUG1 regulates the oral squamous cell
carcinoma progression possibly via interacting with Wnt/β-catenin
signaling. Gene. 608:49–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang
F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1
promotes proliferation and migration of esophageal squamous cell
carcinoma. Tumour Biol. 36:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma
P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in
hepatocellular carcinoma and promotes cell growth and apoptosis by
epigenetically silencing of KLF2. Mol Cancer. 14:1652015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng B, Ye H, Chen J, Cheng D, Cai C, Chen
G, Chen X, Xin H, Tang C and Zeng J: LncRNA TUG1 sponges miR-145 to
promote cancer progression and regulate glutamine metabolism via
Sirt3/GDH axis. Oncotarget. 8:113650–113661. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y,
Li Z, Shang X and Liu Y: The long noncoding RNA TUG1 regulates
blood-tumor barrier permeability by targeting miR-144. Oncotarget.
6:19759–19779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu Y, Sun X, Mao C, Guo G, Ye S, Xu J, Zou
R, Chen J, Wang L, Duan P and Xue X: Upregulation of long noncoding
RNA TUG1 promotes cervical cancer cell proliferation and migration.
Cancer Med. 6:471–482. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017.PubMed/NCBI
|
|
32
|
Qin CF and Zhao FL: Long non-coding RNA
TUG1 can promote proliferation and migration of pancreatic cancer
via EMT pathway. Eur Rev Med Pharmacol Sci. 21:2377–2384.
2017.PubMed/NCBI
|
|
33
|
Li T, Liu Y, Xiao H and Xu G: Long
non-coding RNA TUG1 promotes cell proliferation and metastasis in
human breast cancer. Breast Cancer. 24:535–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Iliev R, Kleinova R, Juracek J, Dolezel J,
Ozanova Z, Fedorko M, Pacik D, Svoboda M, Stanik M and Slaby O:
Overexpression of long non-coding RNA TUG1 predicts poor prognosis
and promotes cancer cell proliferation and migration in high-grade
muscle-invasive bladder cancer. Tumour Biol. 37:13385–13390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun J, Ding C, Yang Z, Liu T, Zhang X,
Zhao C and Wang J: The long non-coding RNA TUG1 indicates a poor
prognosis for colorectal cancer and promotes metastasis by
affecting epithelial-mesenchymal transition. J Transl Med.
14:422016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Niu Y, Ma F, Huang W, Fang S, Li M, Wei T
and Guo L: Long non-coding RNA TUG1 is involved in cell growth and
chemoresistance of small cell lung cancer by regulating LIMK2b via
EZH2. Mol Cancer. 16:52017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Long J, Menggen Q, Wuren Q, Shi Q and Pi
X: Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) promotes
tumor growth and metastasis through
TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) axis in malignant
melanoma. Med Sci Monit. 24:1547–1559. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lei H, Gao Y and Xu X: LncRNA TUG1
influences papillary thyroid cancer cell proliferation, migration,
and EMT formation through targeting miR-145. Acta Biochim Biophys
Sin. 49:588–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma F, Wang SH, Cai Q, Jin LY, Zhou D, Ding
J and Quan ZW: Long non-coding RNA TUG1 promotes cell proliferation
and metastasis by negatively regulating miR-300 in gallbladder
carcinoma. Biomed Pharmacother. 88:863–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baratieh Z, Khalaj Z, Honardoost MA,
Emadi-Baygi M, Khanahmad H, Salehi M and Nikpour P: Aberrant
expression of PlncRNA-1 and TUG1: Potential biomarkers for gastric
cancer diagnosis and clinically monitoring cancer progression.
Biomark Med. 11:1077–1090. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin PC, Huang HD, Chang CC, Chang YS, Yen
JC, Lee CC, Chang WH, Liu TC and Chang JG: Long noncoding RNA TUG1,
is downregulated in non-small cell lung cancer and can regulate
CELF1, on binding to PRC2. BMC Cancer. 16:5832016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang T, Cheng Y, She Q, Jiang Y, Chen Y,
Yang W and Li Y: Long non-coding RNA TUG1 sponges miR-197 to
enhance cisplatin sensitivity in triple negative breast cancer.
Biomed Pharmacother. 107:338–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Niland CN, Merry CR and Khalil AM:
Emerging roles for long non-coding RNAs in cancer and neurological
disorders. Front Genet. 3:252012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cai H, Liu X, Zheng J, Xue Y, Ma J, Li Z,
Xi Z, Li Z, Bao M and Liu Y: Long non-coding RNA taurine
upregulated 1 enhances tumor-induced angiogenesis through
inhibiting microRNA-299 in human glioblastoma. Oncogene.
36:318–331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the Notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7:136162016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Long J, Badal SS, Ye Z, Wang Y, Ayanga BA,
Galvan DL, Green NH, Chang BH, Overbeek PA and Danesh FR: Long
noncoding RNA Tug1 regulates mitochondrial bioenergetics in
diabetic nephropathy. J Clin Invest. 126:4205–4218. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kondo Y, Shinjo K and Katsushima K: Long
non-coding RNAs as an epigenetic regulator in human cancers. Cancer
Sci. 108:1927–1933. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chiu HS, Somvanshi S, Patel E, Chen TW,
Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS; Cancer Genome
Atlas Research Network, ; et al: Pan-cancer analysis of lncRNA
regulation supports their targeting of cancer genes in each tumor
context. Cell Rep. 23:297–312.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales DR, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wahlestedt C: Targeting long non-coding
RNA to therapeutically upregulate gene expression. Nat Rev Drug
Discov. 12:433–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ciferri C, Lander GC, Maiolica A, Herzog
F, Aebersold R and Nogales E: Molecular architecture of human
polycomb repressive complex 2. Elife. 1:e000052012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yoon JH, Abdelmohsen K and Gorospe M:
Functional interactions among microRNAs and long noncoding RNAs.
Semin Cell Dev Biol. 34:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhu J, Shi H, Liu H, Wang X and Li F: Long
non-coding RNA TUG1 promotes cervical cancer progression by
regulating the miR-138-5p-SIRT1 axis. Oncotarget. 8:65253–65264.
2017.PubMed/NCBI
|
|
56
|
Xie Y and Zhong DW: AEG-1 is associated
with hypoxia-induced hepatocellular carcinoma chemoresistance via
regulating PI3K/AKT/HIF-1alpha/MDR-1 pathway. EXCLI J. 15:745–757.
2016.PubMed/NCBI
|
|
57
|
He W, He S, Wang Z, Shen H, Fang W, Zhang
Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated
gene-1(AEG-1) induces epithelial-mesenchymal transition in lung
cancer through activating Wnt/β-catenin signaling. BMC Cancer.
15:1072015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yan G, Wang X, Yang M, Lu L and Zhou Q:
Long non-coding RNA TUG1 promotes progression of oral squamous cell
carcinoma through upregulating FMNL2 by sponging miR-219. Am J
Cancer Res. 7:1899–1912. 2017.PubMed/NCBI
|
|
59
|
Zhao XB and Ren GS: LncRNA
taurine-upregulated gene 1 promotes cell proliferation by
inhibiting MicroRNA-9 in MCF-7 cells. J Breast Cancer. 19:349–357.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yang B, Tang X, Wang Z, Sun D, Wei X and
Ding Y: TUG1 promotes prostate cancer progression by acting as a
ceRNA of miR-26a. Biosci Rep. 38(pii): BSR20180677. 2018.
|
|
61
|
Zhao L, Sun H, Kong H, Chen Z, Chen B and
Zhou M: The Lncrna-TUG1/EZH2 axis promotes pancreatic cancer cell
proliferation, migration and EMT phenotype formation through
sponging Mir-382. Cell Physiol Biochem. 42:2145–2158. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Guo P, Zhang G, Meng J, He Q, Li Z and
Guan Y: Upregulation of long non-coding RNA TUG1 promotes bladder
cancer cell proliferation, migration, and invasion by inhibiting
miR-29c. Oncol Res. 26:1083–1091. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu Q, Liu H, Cheng H, Li Y, Li X and Zhu
C: Downregulation of long noncoding RNA TUG1 inhibits proliferation
and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder
cancer cells. Onco Targets Ther. 10:2461–2471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li J, Zhang Q, Fan X, Mo W, Dai W, Feng J,
Wu L, Liu T, Li S, Xu S, et al: The long noncoding RNA TUG1 acts as
a competing endogenous RNA to regulate the Hedgehog pathway by
targeting miR-132 in hepatocellular carcinoma. Oncotarget.
8:65932–65945. 2017.PubMed/NCBI
|
|
66
|
Bakshi A, Chaudhary SC, Rana M, Elmets CA
and Athar M: Basal cell carcinoma pathogenesis and therapy
involving hedgehog signaling and beyond. Mol Carcinog.
56:2543–2557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lv J, Kong Y, Gao Z, Liu Y, Zhu P and Yu
Z: LncRNA TUG1 interacting with miR-144 contributes to
proliferation, migration and tumorigenesis through activating the
JAK2/STAT3 pathway in hepatocellular carcinoma. Int J Biochem Cell
Biol. 101:19–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Xie C, Chen B, Wu B, Guo J and Cao Y:
LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in
osteosarcoma by regulating miR-212-3p/FOXA1 axis. Biomed
Pharmacother. 97:1645–1653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li G, Liu K and Du X: Long non-coding RNA
TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma
cells by sponging miR-132-3p and Upregulating SOX4 expression.
Yonsei Med J. 59:226–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cao J, Han X, Qi X, Jin X and Li X: TUG1
promotes osteosarcoma tumorigenesis by upregulating EZH2 expression
via miR-144-3p. Int J Oncol. 51:1115–1123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wang H, Yu Y, Fan S and Luo L: Knockdown
of long noncoding RNA TUG1 inhibits the proliferation and cellular
invasion of osteosarcoma cells by sponging MiR-153. Oncol Res.
26:665–673. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Xie CH, Cao YM, Huang Y, Shi QW, Guo JH,
Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1
contributes to tumorigenesis of human osteosarcoma by sponging
miR-9-5p and regulating POU2F1 expression. Tumour Biol.
37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li Y, Zhang T, Zhang Y, Zhao X and Wang W:
Targeting the FOXM1-regulated long non-coding RNA TUG1 in
osteosarcoma. Cancer Sci. 109:3093–3104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Liao WT, Jiang D, Yuan J, Cui YM, Shi XW,
Chen CM, Bian XW, Deng YJ and Ding YQ: HOXB7 as a prognostic factor
and mediator of colorectal cancer progression. Clin Cancer Res.
17:3569–3578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang E, He X, Yin D, Han L, Qiu M, Xu T,
Xia R, Xu L, Yin R and De W: Increased expression of long noncoding
RNA TUG1 predicts a poor prognosis of gastric cancer and regulates
cell proliferation by epigenetically silencing of p57. Cell Death
Dis. 7:e21092016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia
S, Wang Y, Liu Y and Shi G: KLF9, a transcription factor induced in
flutamide-caused cell apoptosis, inhibits AKT activation and
suppresses tumor growth of prostate cancer cells. Prostate.
74:946–958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Liu H, Zhou G, Fu X, Cui H, Pu G, Xiao Y,
Sun W, Dong X, Zhang L, Cao S, et al: Long noncoding RNA TUG1 is a
diagnostic factor in lung adenocarcinoma and suppresses apoptosis
via epigenetic silencing of BAX. Oncotarget. 8:101899–101910.
2017.PubMed/NCBI
|
|
79
|
Li T, Chen Y, Zhang J and Liu S: LncRNA
TUG1 promotes cells proliferation and inhibits cells apoptosis
through regulating AURKA in epithelial ovarian cancer cells. Med
(Baltimore). 97:e121312018. View Article : Google Scholar
|
|
80
|
Yang LY, He CY, Chen XH, Su LP, Liu BY and
Zhang H: Aurora kinase A revives dormant laryngeal squamous cell
carcinoma cells via FAK/PI3K/Akt pathway activation. Oncotarget.
7:48346–48359. 2016.PubMed/NCBI
|
|
81
|
Schnepp RW, Khurana P, Attiyeh EF, Raman
P, Chodosh SE, Oldridge DA, Gagliardi ME, Conkrite KL, Asgharzadeh
S, Seeger RC, et al: A LIN28B-RAN-AURKA signaling network promotes
neuroblastoma tumorigenesis. Cancer Cell. 28:599–609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang L, Zhao Z, Feng W, Ye Z, Dai W, Zhang
C, Peng J and Wu K: Long non-coding RNA TUG1 promotes colorectal
cancer metastasis via EMT pathway. Oncotarget. 7:51713–51719.
2016.PubMed/NCBI
|
|
83
|
Yin DD, Zhang EB, You LH, Wang N, Wang LT,
Jin FY, Zhu YN, Cao LH, Yuan QX, De W and Tang W: Downregulation of
lncRNA TUG1 affects apoptosis and insulin secretion in mouse
pancreatic β cells. Cell Physiol Biochem. 35:1892–1904. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sun JF, Hu JY, Wang GJ, Yang Z, Zhao C,
Zhang X and Wang J: LncRNA TUG1 promoted KIAA1199 expression via
miR-600 to accelerate cell metastasis and epithelial-mesenchymal
transition in colorectal cancer. J Exp Clin Cancer Res. 37:1062018.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang Y, Yang T, Zhang Z, Lu M, Zhao W,
Zeng X and Zhang W: Long non-coding RNA TUG1 promotes migration and
invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.
Cancer Sci. 108:859–867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ji TT, Huang X, Jin J, Pan SH and Zhuge
XJ: Inhibition of long non-coding RNA TUG1 on gastric cancer cell
transference and invasion through regulating and controlling the
expression of miR-144/c-Met axis. Asian Pac J Trop Med. 9:508–512.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
He C, Liu Z, Jin L, Zhang F, Peng X, Xiao
Y, Wang X, Lyu Q and Cai X: lncRNA TUG1-mediated Mir-142-3p
downregulation contributes to metastasis and the
Epithelial-to-Mesenchymal transition of hepatocellular carcinoma by
targeting ZEB1. Cell Physiol Biochem. 48:1928–1941. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lin YH, Wu MH, Huang YH, Yeh CT, Cheng ML,
Chi HC, Tsai CY, Chung IH, Chen CY and Lin KH: Taurine up-regulated
gene 1 functions as a master regulator to coordinate glycolysis and
metastasis in hepatocellular carcinoma. Hepatology. 67:188–203.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Li C, Gao Y, Li Y and Ding D: TUG1
mediates methotrexate resistance in colorectal cancer via
miR-186/CPEB2 axis. Biochem Biophys Res Commun. 491:552–557. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Shafiee SM, Rasti M, Seghatoleslam A,
Azimi T and Owji AA: UBE2Q1 in a human breast carcinoma cell line:
Overexpression and interaction with p53. Asian Pac J Cancer Prev.
16:3723–3727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lee K, Jung ES, Choi YJ, Lee KY and Lee A:
Expression of pRb, p53, p16 and cyclin D1 and their clinical
implications in urothelial carcinoma. J Korean Med Sci.
25:1449–1455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Jiang L, Zhang Q, Ren H, Ma S, Lu C, Liu
B, Liu J, Liang J, Li M and Zhu R: Dihydromyricetin enhances the
chemo-sensitivity of nedaplatin via regulation of the p53/Bcl-2
pathway in hepatocellular carcinoma cells. PLoS One.
10:e01249942015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Elhag R, Mazzio EA and Soliman KF: The
effect of silibinin in enhancing toxicity of temozolomide and
etoposide in p53 and PTEN-mutated resistant glioma cell lines.
Anticancer Res. 35:1263–1269. 2015.PubMed/NCBI
|
|
96
|
Pilarsky C, Wenzig M, Specht T, Saeger HD
and Grützmann R: Identification and validation of commonly
overexpressed genes in solid tumors by comparison of microarray
data. Neoplasia. 6:744–750. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Okabe H, Satoh S, Kato T, Kitahara O,
Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y:
Genome-wide analysis of gene expression in human hepatocellular
carcinomas using cDNA microarray: Identification of genes involved
in viral carcinogenesis and tumor progression. Cancer Res.
61:2129–2137. 2001.PubMed/NCBI
|
|
98
|
Li J, Zhang M, An G and Ma Q: Long
non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells.
Biochem Biophys Res Commun. 477:743–748. 2016. View Article : Google Scholar : PubMed/NCBI
|
